HCL Tech

OCTOBER 16, 2024

Our Global Pharmacovigilance and Epidemiology (GPV&E) team will demonstrate our ability to capture, analyze and visualize a comprehensive 360° view of healthcare product safety. We are at the forefront of revolutionizing pharmacovigilance (PV) by leveraging cutting-edge AI technologies and extensive industry knowledge.

Healthcare 98

Healthcare Pharmaceutics Phone Technology 98

HCL Tech

SEPTEMBER 10, 2024

Banner CTA Harmonizing technology and humanity in healthcare and life sciences As this industry continues to evolve, automation and AI are crucial to remaining competitive. Today’s automation technologies usher greater efficiency and cost optimization for pharmaceutical companies, biotech firms and healthcare providers and payers.

Healthcare 52

Healthcare Pharmaceutics Technology Platform 52

HCL Tech

SEPTEMBER 2, 2024

The HCLTech Global Pharmacovigilance and Epidemiology (GPV&E) team will showcase how we effectively capture, analyze and aggregate a rich 360° view of healthcare products' safety profiles. Our global team of experienced healthcare professionals combines industry expertise with advanced technologies.

Pharmaceutics 52

Pharmaceutics Healthcare Phone Technology 52

HCL Tech

SEPTEMBER 3, 2024

The HCLTech Global Pharmacovigilance and Epidemiology (GPV&E) team will demonstrate our capability to comprehensively capture, analyze, and aggregate an extensive 360° perspective on the safety profiles of healthcare products.

Healthcare 52

Healthcare Pharmaceutics Platform Technology 52

Airtel

OCTOBER 17, 2024

In a nation where healthcare often comes at a steep price, Ritesh Deshmukh’s hard-hitting “Pill Series” takes a scalpel to the festering wounds of India’s pharmaceutical industry. The writers have done their homework, drawing from real-life scandals that have rocked the pharmaceutical world.

Pharmaceutics 52

Pharmaceutics Healthcare Marketing Platform 52

HCL Tech

JANUARY 13, 2025

A Europe-based biopharma major and one of the worlds largest pharmaceutical and biomedical companies selected HCLTech to establish an innovative, enterprise-based digital hub leveraging its platform engineering and GenAI capabilities. Consolidated revenues as of 12 months ending December 2024 totaled $13.8

Retail 72

Retail Pharmaceutics Media Entertainment 72

HCL Tech

SEPTEMBER 3, 2024

The HCLTech Global Pharmacovigilance and Epidemiology (GPV&E) team will demonstrate our capability to comprehensively capture, analyze, and aggregate an extensive 360° perspective on the safety profiles of healthcare products. Our global team of experienced healthcare professionals combines industry expertise with advanced technologies.

Healthcare 52

Healthcare Pharmaceutics Phone Technology 52